Ofichem is a leading CDMO with a broad range of services, offering drug substance and drug product development and manufacturing, with facilities in the Netherlands and Sweden. Ofichem focuses on the procurement, development, production, and analysis of both drug substances and drug products. Ofichem has its own portfolio of high-quality APIs, but also works as a CDMO from preclinical to commercial stages.
Preclinical services include medicinal chemistry, process development, analytical chemistry, and formulation development for both small molecules and new modalities such as bioconjugates, oligonucleotides, and PROTACs.
Ofichem offers GMP manufacturing of small-molecule APIs for clinical studies and commercial volumes. Drug product development and GMP production can also be offered, including large-scale manufacturing of tablets and packaging in blisters or bottles.
With strong global relationships, Ofichem can also support sourcing quality pharmaceutical ingredients for human and veterinary use.
As a stable family-owned business with 50 years of experience, Ofichem has a long history of regulatory compliance and a strong reputation for reliability, safety, and quality.
Key Products and Services:
- Active Pharmaceutical Ingredients (APIs)
- Contract Manufacturing Organisation (CMO) services
- Research and Development (R&D) of APIs
- Manufacturing of APIs
- Research and Development (R&D) of drug products
- Manufacturing of Oral Solid Dose (OSD) products
- Physical and chemical analyses
- Sampling and repacking
- Strategic sourcing
- Audits for GMP evaluation
